wire - news in brief

« BACK

Medicine/Pharmacology



Results 1 - 50 of 1437.
1 2 3 4 5 ... 29 Next »


Medicine / Pharmacology - Business / Economics - 18.05.2018
Novartis and Amgen announce FDA approval of Aimovig(TM) (erenumab), a novel treatment developed specifically for migraine prevention
Migraine is a severe neurologic disease that profoundly impacts millions of patients in the United States   Aimovig is the first and only FDA-approved treatment to block the calcitonin gene-related p

Medicine / Pharmacology - Life Sciences - 17.05.2018
Novartis data at ASCO and EHA reinforce company’s commitment to reimagining cancer
Results from the Kisqali MONALEESA clinical trial program, the largest industrysponsored Phase III registration program researching a CDK4/6 inhibitor in HR+/HER2- advanced breast cancer, will be pre

Life Sciences - Medicine / Pharmacology - 17.05.2018
Blocking two enzymes could make cancer cells mortal
EPFL scientists have identified two enzymes that protect chromosomes from oxidative damage and shortening.

Medicine / Pharmacology - Life Sciences - 17.05.2018
Follow-up phase III data showed Roche’s Alecensa helped people with ALK-positive metastatic non-small cell lung cancer live a median of almost three years without their disease worsening or death
Follow-up phase III data showed Roche's Alecensa helped people with ALK-positive metastatic non-small cell lung cancer live a median of almost three years without their disease worsening or death Inv

Medicine / Pharmacology - Life Sciences - 17.05.2018
Phase III IMpower150 study showed Roche’s Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avastin plus carboplatin and paclitaxel
Phase III IMpower150 study showed Roche's Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avas

Life Sciences - Medicine / Pharmacology - 16.05.2018
Cellular Valve Structure Opens Up Potential Novel Therapies
Cellular Valve Structure Opens Up Potential Novel Therapies
Human cells are enclosed by membranes and are in osmotic equilibrium with their environment. If the concentration of solute molecules (osmolarity) in the fluid surrounding the cells decreases, cells start to swell; in extreme cases, this can result in the cells bursting.

Business / Economics - Medicine / Pharmacology - 16.05.2018

Medicine / Pharmacology - Business / Economics - 15.05.2018

Medicine / Pharmacology - Business / Economics - 15.05.2018

Medicine / Pharmacology - Life Sciences - 12.05.2018
Novartis announces FDA approval of Gilenya as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
New approval for Gilenya (fingolimod) addresses strong unmet need for younger patients, who often experience more frequent relapses than adults with multiple sclerosis (MS)   In a landmark controlled

Medicine / Pharmacology - Innovation / Technology - 09.05.2018

Life Sciences - Medicine / Pharmacology - 09.05.2018
Human MAIT cells sense the metabolic state of enteric bacteria
Human MAIT cells sense the metabolic state of enteric bacteria
A little-explored group of immune cells plays an important role in the regulation of intestinal bacteria. Changing metabolic states of the microbes have an effect on defense cells at different stages of alert or rest, as researchers from the Department of Biomedicine at the University and University Hospital of Basel report in the journal "Mucosal Immunology." It is known that the metabolites of bacteria influence the composition and function of immune cells resident within the gut.

Medicine / Pharmacology - Business / Economics - 08.05.2018

Innovation / Technology - Medicine / Pharmacology - 07.05.2018

Medicine / Pharmacology - Business / Economics - 07.05.2018

Medicine / Pharmacology - Environment / Sustainable Development - 30.04.2018
Seven Marie Curie Fellowships for the University of Bern
Each year, the European Commission awards Marie Sk?odowska-Curie Individual Fellowships to post-doctoral researchers.

Medicine / Pharmacology - 30.04.2018
New Novartis Phase III data for brolucizumab demonstrate reliability of 12-week treatment interval
Patients identified for brolucizumab 12-week treatment interval in Phase III HAWK and HARRIER trials had an 87% and 83% probability of successfully continuing on a 12-week interval through week 48 Pr

Medicine / Pharmacology - Administration / Government - 30.04.2018
Novartis receives FDA approval of Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma
Tafinlar + Mekinist is the first oral targeted adjuvant combination therapy to demonstrate significant clinical benefit in patients with a BRAF V600 mutation, following complete surgical resection  

Event - Medicine / Pharmacology - 28.04.2018

Medicine / Pharmacology - Environment / Sustainable Development - 23.04.2018
Frequent walking: from personal health to sustainable mobility
For his thesis, Derek Christie studied people who walk outdoors for more than one hour per day. Little research has been done into these frequent walkers, who could nevertheless help to shape public policies on mobility.

Medicine / Pharmacology - Social Sciences - 20.04.2018
How Do People Die in Switzerland Today?
Across all regions, in more than three quarters of cases deaths were preceded by at least one end-of-life decision. (Image: Istock.com/LPETTET) Today, almost two thirds of deaths in Switzerland are foreseeable due to old age or terminal illness. This means that difficult end-of-life decision have to be made.

Medicine / Pharmacology - Administration / Government - 19.04.2018

Medicine / Pharmacology - Business / Economics - 17.04.2018
Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials
Company to invest more than USD 100 million to advance research and development of new antimalarials over the next five years   Commitment includes expanding access to pediatric antimalarials and imp

Business / Economics - Medicine / Pharmacology - 17.04.2018

Medicine / Pharmacology - Physics / Materials Science - 17.04.2018
Novartis presents first-of-its-kind evidence at AAN reinforcing robust and consistent efficacy of AimovigTM* (erenumab) for migraine patients with multiple treatment failures
Novartis presents first-of-its-kind evidence at AAN reinforcing robust and consistent efficacy of AimovigTM* (erenumab) for migraine patients with multiple treatment failures The LIBERTY trial studie

Medicine / Pharmacology - Administration / Government - 16.04.2018
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes Heart failure (HF) patients with reduced

Life Sciences - Medicine / Pharmacology - 16.04.2018
Basel researchers succeed in cultivating cartilage from stem cells
Basel researchers succeed in cultivating cartilage from stem cells
Stable joint cartilage can be produced from adult stem cells originating from bone marrow.

Medicine / Pharmacology - Life Sciences - 12.04.2018
Five proposals win initial
Five proposals win initial "catalyst" funding
Researchers from Campus Biotech were invited to develop joint projects with partner research institutes and bid for funding from the Bertarelli Foundation.

Medicine / Pharmacology - Innovation / Technology - 07.04.2018
Sandoz outlines plans for next Healthcare Access Challenge (HACk), to support local digital innovation
Sandoz White Paper outlines importance of digital solutions to specific local healthcare problems, as part of approach to increasing access to healthcare Publication, which coincides with World Healt

Medicine / Pharmacology - Business / Economics - 06.04.2018

Medicine / Pharmacology - Social Sciences - 04.04.2018
Novartis announces JAMA Cardiology publication of data showing Entresto improves physical and social activity in HFrEF patients versus enalapril
Novartis announces JAMA Cardiology publication of data showing Entresto improves physical and social activity in HFrEF patients versus enalapril Post-hoc analysis of PARADIGM-HF published in JAMA Car

Medicine / Pharmacology - Life Sciences - 04.04.2018
Enhanced therapeutic vaccine platform achieves two proof of concepts in veterinary medical use
Enhanced therapeutic vaccine platform achieves two proof of concepts in veterinary medical use
Chronical allergic diseases of dogs and horses can now be treated with an innovative vaccine. It was developed by an international research team led by he University of Bern and in cooperation with the University of Zurich, together with private enterprise companies. The findings obtained in horses and dogs could lead to similar herapeutic vaccines for humans.

Medicine / Pharmacology - Life Sciences - 04.04.2018
Therapeutic vaccine platform achieves proof of concepts in veterinary medical use
Scientists from the Universities of Bern, Zurich and Oxford as well as the Latvian Biomedical Research & Study Centre led by Prof. Martin F. Bachmann (University Clinic of Rheumatology, Immunoloy and Allergology, University of Bern) have developed a new therapeutic vaccine technology based upon enhanced virus like nanoparticle conjugates.

Medicine / Pharmacology - Innovation / Technology - 28.03.2018
An EPFL startup raises 20 million francs
An EPFL startup raises 20 million francs
Abionic, an EPFL spin-off, has just brought in 20 million francs in its third funding round. The company's rapid allergy test can now be used to detect sepsis as well.

Medicine / Pharmacology - 28.03.2018
Novartis to present predictability data for brolucizumab in nAMD from pivotal HAWK and HARRIER trials at ARVO
Novartis will present new data from the HAWK and HARRIER Phase III trials at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting, Honolulu, April 29 - May 3.

Medicine / Pharmacology - Life Sciences - 26.03.2018
Healing instead of cutting down
Healing instead of cutting down
Trees can get sick too. In urban areas, this usually means that the infested tree has to be felled for safety reasons.

Medicine / Pharmacology - Life Sciences - 23.03.2018
1 2 3 4 5 ... 29 Next »